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Preterm birth as a marker for women’s and 
children’s health
Th e Born Too Soon report, published in 2012, drew global 
attention to the issue of preterm birth and reported that 
more than 1 in 10 of the world’s babies are born too soon 
each year, 15  million each year [1]. As part of a series 
entitled “Born Too Soon” drawing from the report, this 
ﬁ nal paper summarises the problem, underlining the 
need for concerted action on both the prevention of 
preterm birth and care of the premature baby, to ensure 
every mother and every baby survives [2-6]. We then 
highlight evidence-based inter ventions for preterm birth 
in the context of the wider health system drawing on the 
other papers in this supple ment, and here we focus on 
the implications for integrating and scaling up those 
available interventions in low- and middle-income 
countries where the coverage of care is lowest and the 
potential lives saved as a result. We also consider research 
gaps since advancing the research agenda is a critical 
need to reduce the global burden of preterm birth, 
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requiring innovations for both prevention and care. 
Finally we detail the analyses for a mortality reduction 
target for preterm speciﬁ c neonatal deaths and outline 
the speciﬁ c roles all actors must play in this global eﬀ ort 
to reduce preterm birth and care for premature babies, 
which is a marker of the health and care of women and 
girls, as well as of progress for child survival and 
development.
Th e actions identiﬁ ed aim to support the goals of the 
Global Strategy for Women’s and Children’s Health 
launched by the United Nations (UN) Secretary-General 
Ban Ki-moon in September 2010 to further advance 
progress for the Millennium Development Goal 4 for 
child survival and the Every Woman Every Child 
movement to mobilise action and resources for these 
goals [7]. By pooling our eﬀ orts with each organisation 
playing to its strengths, our shared goal, as epitomised in 
Every Woman Every Child, can be realised — a day when 
pregnancies are wanted and safe, women survive, babies 
everywhere get a healthy start in life, and children thrive.
Accelerating evidence-based action for prevention 
and care
Addressing the burden of preterm birth has a dual 
track—prevention and care (Figure  1). Reducing risks 
before, during, and between pregnancies through 
preconception and antenatal care packages may help 
preterm birth prevention [4,5]. Actions taken during 
labour and birth, and particularly improved care of the 
neonate have been shown to have major impact [5, 6]. For 
example, antenatal corticosteroids administered to a 
preg nant woman in preterm labour can prevent respira-
tory distress syndrome in premature babies reducing 
newborn mortality and morbidity [5]. In addition, many 
of these interventions, such as obstetric care and 
antibiotics for prelabour premature rupture of 
membranes (pPROM), also beneﬁ t maternal health and 
prevent stillbirths [8]. Interventions that have been 
identiﬁ ed through global reviews of the evidence are 
summarised elsewhere [4-6] and shown in Figure 1.
Prevention of preterm birth is primarily a knowledge gap
Despite the burden of preterm birth, few eﬀ ective 
prevention strategies are available for clinicians, policy-
makers and program managers. Multiple studies in high-
income contexts have attempted to prevent preterm 
birth, but have not yet identiﬁ ed high-impact interven-
tions in the preconception and antenatal periods. Many 
interventions have been evaluated, and some have been 
identiﬁ ed as beneﬁ cial though limited in public health 
impact, such as therapy with progestational agents, which 
have only been studied in certain high-risk populations. 
Preliminary studies of interventions to reduce rates of 
elective caesarean births or inductions without medical 
indication before the recommended 39 completed weeks 
of gestation suggest an impact on prevention of early 
term deliveries in some high- and middle-income 
countries [9,10]. A recent study published in Th e Lancet 
examined preterm birth prevention potential in 39 high-
income countries and estimated that if ﬁ ve interventions 
reached high coverage there would only be a 5% relative 
reduction of preterm birth rate from 9·59% to 9·07% of 
livebirths by 2015, averting an estimated 58,000 preterm 
births and saving US$3 billion annually [11]. Th ese ﬁ ve 
interventions were: smoking cessation (0·01 rate reduc-
tion), decreasing multiple embryo transfers during 
assisted reproductive technologies (0·06), cervical cerclage 
(0·15), use of progesterone agents (0·01), and reduction of 
elective labour induction or caesarean delivery without 
medical indication (0·29). Th e limited number and 
eﬀ ectiveness of available interventions for preterm 
prevention further underscores this critical major 
knowledge gap, and makes the case for a strategic and 
coordinated research eﬀ ort to advance understanding of 
causes and mechanisms of preterm birth and identi ﬁ -
cation of innovative solutions.
However, the low- and middle -income countries with 
the highest burden of preterm births also carry the 
greatest burden of higher-risk conditions for preterm 
birth that are preventable or treatable. Interventions such 
as family planning; prevention and management of 
sexually transmitted infections (STIs); use of insecticide-
treated bednets and intermittent preventive treatment 
for malaria; identiﬁ cation and treatment of pre-
eclampsia, and reduction of physical workload are 
examples of strategies that could improve birth outcomes 
in in low- and middle-income settings. Unfortunately, to 
date, few studies have assessed the impact of these inter-
ventions on preterm birth in these countries, particularly 
with accurate measures of gestational age [12]. Th e 
greatest potential for the global prevention of preterm 
birth, therefore, lies in a comprehensive, strategic, and 
suﬃ  ciently-funded research agenda of the causes of 
preterm birth and novel strategies for prevention [13]. 
Th is should be vigorously pursued.
Th ere are some signiﬁ cant intrapartum interventions 
that reduce the impact of preterm birth. Antenatal 
corticosteroid injections given to women in preterm 
labour are highly eﬀ ective at preventing respiratory 
distress syndrome in premature babies and associated 
mortality and long-term impairment, but remain under-
used in many low- and some middle-income countries. 
Th ere is, thus, a need for delivery research that can help 
understand context-speciﬁ c reasons for the continued 
low coverage in these countries and identify ways to 
adapt known eﬀ ective strategies for use in low-resource 
settings [14]. Tocolytic medicines rarely stop preterm 
labour, but may help delay labour for hours or days, 
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allowing the baby additional precious time to develop 
before birth. Of course, any strategies to prolong labour, 
including delaying caesarean birth, must be evaluated 
against the potential risk of continued exposure of 
woman and foetus to sub-optimal conditions that may 
result in harmful eﬀ ects. Further research is needed on 
short and long-term health consequences for mother and 
baby from eﬀ orts to prevent preterm labour [5] .
Care of premature babies is primarily an action gap
As evidenced by the large survival gap between babies 
born in high-income countries and those born in low- 
and middle-income countries, eﬀ ective interventions 
exist to reduce death and disability in premature babies, 
yet this care does not reach the poor and most 
disadvantaged populations where the burden is highest 
[6]. Th ere is a “know-do gap”, or a gap between what is 
known to work and what is done in practice. Bridging 
this gap will be critical for saving premature babies 
globally, and must be linked to implementation research 
and context speciﬁ c adaptation and innovation.
More than 60% of all premature babies are born in 
South Asia and sub-Saharan Africa which have the 
highest preterm birth rates [15] and half of births are 
currently in facilities. Most preterm births occur over 32 
weeks of gestation (84%), and deaths in these babies can 
almost all be prevented and in most cases, intensive care 
is not needed [6] (Figure 1). It is possible to implement 
some evidence-based interventions for the care of 
premature babies at the community level through 
behaviour change initiatives and women’s groups [16], as 
well as home-visit packages with extra care for premature 
babies, particularly breastfeeding support and awareness 
of the importance of seeking care when danger signs 
occur [17]. In a few countries, case management of 
neonatal sepsis is being scaled up using community-
based health workers [18]. However, the highest impact 
interventions, notably access to quality intrapartum care 
and emergency obstetric and newborn care [19], require 
facility-based services. Antenatal corticosteroids and 
Kangaroo Mother Care (KMC) are evidence-based 
interventions that are feasible to scale up in low-resource 
settings and may serve as entry points for strengthening 
health systems [20,21].
Scaling up preterm birth interventions within the 
existing health system
Th ere is increasing global consensus around essential 
reproductive, maternal, newborn and child health 
(RMNCH) interventions [22,23], including those to 
address preterm birth (Figure 2). Th e goal is to achieve 
universal, equitable coverage and high quality in all these 
RMNCH interventions. Newborn babies, and especially 
premature newborns, are the most sensitive test of health 
Figure 1. Approaches to prevent preterm birth and reduce deaths among premature babies. Source: Born Too Soon, Chapter 6 [75]. 
Dean et al., 2013 [4]; Requejo et al., 2013 [5]; Lawn et al., 2013 [6].
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systems function as these babies can die within minutes 
without the right care. For sustainable eﬀ ect, inter-
ventions to prevent preterm birth in the preconception 
and antenatal periods and to reduce death and disability 
in premature babies must be integrated within the 
existing health system.
Th e continuum of care is a core organising principle for 
health systems emphasising linkages between healthcare 
packages across time and through various service 
delivery strategies [2]. An eﬀ ective continuum of care 
addresses the health needs of the adolescent, woman, 
mother, newborn and child throughout the life cycle, 
wherever care is provided, whether it be at the home, 
primary care level or district and regional hospitals. 
Integrated service delivery packages of evidence-based 
interventions within the continuum of care have many 
advantages: cost-eﬀ ectiveness is enhanced; available 
human resources are maximised; and services are more 
family-friendly, reducing the need for multiple visits [24]. 
Most importantly, they can help prevent stillbirths, 
improve prevention and care of premature babies and 
avert death and disability in women, newborns and 
children [25-27].
Interventions with the highest impact on the pre-
vention of preterm birth and care of the premature baby 
in high-mortality and lower-resource settings can be 
integrated into these health service delivery packages, 
which exist in most health systems and involve links with 
maternal and child health services, as well as immun-
isation, malaria, HIV/AIDS, nutrition, family planning, 
and other related programs [22]. A schematic matrix of 
the basic health packages (Figure 2) outlines these 
packages spanning the continuum of care and through 
various service delivery modes within the health system, 
highlighting the interventions included to address 
preterm birth. Th e interventions within each package are 
based on multiple systematic reviews and are consistent 
with the Partnership for Maternal, Newborn and Child 
Health Essential Interventions report [23].
While these packages may exist in nearly all health 
systems, lower-income countries cannot scale up and 
implement all the individual RMNCH interventions 
Figure 2. Integrated service delivery packages for maternal, newborn and child health. Source: Born Too Soon, Chapter 6 [75]. Adapted from 
(Kerber et al., 2007; Lawn et al., 2012; PMNCH 2012) [22, 23, 51]. Note: interventions for preterm birth are bold. Acryomns used: ANC = Antenatal 
care; CPAP = Continuous positive airway pressure; HIV = Human Immunodefi ciency Virus; IMCI = Integrated Management of Childhood Illnesses; 
IPTp = Intermittent presumptive treatment during pregnancy for malaria; pPROM = prelabour premature rupture of membranes; STI = Sexually 
Transmitted Illness.
Lawn et al. Reproductive Health 2013, 10(Suppl 1):S6 
http://www.reproductive-health-journal.com/content/10/S1/S6
Page 4 of 20
within all the packages at once [25]. Packages usually are 
initially comprised of the essential interventions and then 
increase in complexity over time according to local needs 
and capacity. For example, the Antenatal Care package 
may start as the WHO focused four visit package and 
then later add on diabetes screening and routine ultra-
sound as the system capacity and funding increases [26]. 
Th e functionality of health systems, such as human 
resource capacity, health facility infrastructure, supply 
and demand systems, ﬁ nancial resources, government 
stewardship, district-level management and use of data, 
will also determine the coverage, quality and rate of 
change within the continuum of care [28].
Closing gaps in coverage, equity and quality
In order for health services to save the maximum number 
of lives, coverage, quality and equity need to be high; thus 
ensuring high coverage of care means reaching every 
woman, mother-to-be, mother, newborn, child and 
family with targeted interventions. Providing quality care 
involves doing the right thing at the right time. Providing 
equitable care means ensuring care for all according to 
need, rather than income, gender or other social group-
ing. Th is holds true for the existing inequalities in care 
within and across high-income as well as low- and 
middle-income countries. Previous papers in this supple-
ment have identiﬁ ed gaps in coverage, quality, equity and 
metrics for care during preconception, pregnancy and 
care of preterm newborns [4-6].
Current coverage levels for eight indicators across the 
continuum of care, chosen by the United Nations Com-
mission on Information and Accountability for Women’s 
and Children’s Health, are tracked for the 75 priority 
Countdown to 2015 countries which collectively account 
for 90% of maternal, newborn and child deaths [29]. 
Currently, essential care reaches only half of the people in 
need (Figure 3), and there is a wide variation in coverage 
levels among countries, with some countries achieving 
nearly universal coverage and others reaching less than a 
quarter of the population. Demand for family planning 
satisﬁ ed and antenatal care coverage, even though 
feasible through primary care services, still leave out 
many women, especially the poorest. In addition, quality 
gaps are a missed opportunity for reaching families; for 
example, when a midwife is present at birth but is not 
equipped to prevent post partum haemorrhage or to 
resuscitate a baby who does not breathe [5,6]. Substantial 
progress is still needed for the reduction of maternal and 
newborn deaths, especially for eﬀ ective, high quality at 
the vital contact times (e.g., skilled attendant at birth and 
postnatal care) [29]. Currently, there are no routine data 
available for many of the interventions for preterm birth 
prevention and care.
A research pipeline to address preterm birth
Greater investment in research and, in particular, into 
discovery of the many complex and interrelated factors 
causing preterm birth is needed to strengthen prevention 
Figure 3. Coverage along the continuum of care for 75 Countdown to 2015 priority countries. Source: Countdown to 2015 (Requejo et al., 
2013) [29]. Note: Eight selected Commission on Information and Accountability for Women’s and Children’s Health indicators, showing median for 
Countdown priority countries. Acryomns used: ANC = Antenatal care; DTP3 = Three doses of diphtheria, tetanus and pertussis vaccine.
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and oﬀ ers a potential over the longer term for signiﬁ cant 
reductions in mortality, childhood disability and health-
care expenditure. For care of preterm babies, the 
emphasis is on rapidly scaling up implementations, so 
that the maximum number of preterm babies and their 
mothers beneﬁ t. Implementation research is needed to 
understand the most eﬃ  cient means of scaling up 
evidenced based solutions. In this way, hundreds of 
thousands of lives could be saved with the application of 
current knowledge.
Preterm birth is not a single condition, but a single 
outcome (birth before 37 completed weeks) due to 
multiple causes. Hence, there will not be a single solution, 
but rather an array of solutions that address the various 
biological, clinical, behavioural and social risk factors 
that result in preterm birth. Th is supplement identiﬁ es 
risks for preterm birth and the solutions needed to 
reduce those risks across the RMNCH continuum; yet for 
many of these risks, we do not have eﬀ ective solutions. 
Important research priorities have been highlighted 
[4-6]. A strategic research approach is needed to under-
stand why babies are born preterm or as stillbirths, how 
to identify women at risk, to test strategies for prevention 
and care, and reduce death and disability rates for 
preterm neonates.
Important research themes can be summarised across 
the research pipeline of description, discovery, develop-
ment and delivery science, showing the dual agenda of 
preventing preterm birth and addressing the care and 
survival gap for babies born preterm (Table 1) [30]. For 
the preterm prevention research agenda, the greatest 
emphasis is on discovery and descriptive research, which 
is a longer-term investment. For the premature baby care 
agenda, the greatest emphasis is on development and 
delivery research, with a shorter timeline to impact at 
scale.
Table 1. A research pipeline advancing knowledge to address preterm birth
 Description Discovery Development Delivery
 Characterise the  Understand the Create and develop Advance equitable access
 problem problem new interventions to interventions
Research aim
Descriptive epidemiology to 
understand determinants, 
advance defi nitions
Development of new 
interventions or adapting 
or improving existing 
interventions
Development of new 
interventions or adapting 
or improving existing 
interventions
Delivery of interventions at scale 
through innovative approaches
Preterm 
prevention 
research 
themes
•  Improve collection, analysis, 
interpretation, application 
of epidemiological data 
for:
»  Refi ning, disseminating 
standard defi nitions of 
exposures, outcomes 
and phenotypes 
»  Further understanding 
of risk factors for 
preterm birth 
»  Monitoring and 
evaluating impact of 
interventions 
»  Improving the estimates 
and data collection 
systems
•  Increase knowledge of 
the biology of normal and 
abnormal pregnancy
•  Better understand 
modifi able mechanisms 
contributing to preterm 
birth (e.g., preconceptual 
or antenatal nutrition, 
infection and immune 
response)
•  Advance understanding 
of underlying patho- 
physiology of preterm 
newborns and impact 
of co-morbidities on 
outcomes in different 
country settings
•  Create, develop new 
interventions (e.g., novel 
approaches to preventing 
preterm birth)
•  Adapt existing 
interventions to increase 
effect, reduce cost, or 
expand utilisation and 
access
•  Evaluate impact, cost 
and process of known 
interventions to reduce 
preterm birth (e.g., family 
planning, STI management, 
malaria prevention)
•  Social behaviour change 
research to address lifestyle 
factors and other risks for 
preterm birth
•  Effective approaches to 
increase use of antenatal 
steroids in low- and middle-
income settings
Premature 
baby care 
research 
themes
•  Create new devices and 
drugs for preterm babies 
that are feasible to use in 
low-income settings
•  Adapt existing 
interventions to increase 
effect, reduce cost, and/
or improve deliverability 
in challenging settings 
or at community level 
(e.g., robust, simpler 
technologies)
•  Implementation research 
to adapt and scale up 
context-specifi c packages 
of care for preterm babies 
(e.g., examining task shifting, 
innovative commodities, etc.)
•  Create and implement 
effective community-based 
approaches (e.g., community 
health workers home visit 
packages, women’s’ groups)
Typical 
timeline to 
impact
Near-term to Long-term 
(2 to 15 years)
Long-term 
(5 to 15 years)
Medium-term 
(5 to 10 years)
Near-term 
(2 to 5 years)
Source: Born Too Soon, Chapter 6 [75]. Adapted from Lawn et al., 2008; Rubens et al., 2010.
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Descriptive research
Improved and consistently applied epidemiologic deﬁ  ni-
tions and methods, with clearly deﬁ ned preterm pheno-
types, are the foundation for improved understanding of 
the burden of preterm birth [31, 32] and addressing the 
multiple and often interrelated causes of preterm birth. 
Simpler and lower-cost methods for measuring gesta-
tional age are particularly needed in low- and middle-
income countries where the burden of preterm birth is 
highest. Social and racial disparities in preterm birth 
rates are a major issue, yet remain poorly under stood. 
Another important need is for standardised methods for 
diagnosing and treating prematurity-related impairment 
in childhood and more consistent measures and timing 
for assessing multi-domain impairments [33,34].
Discovery research
Discovery research focuses on better understanding the 
causes and mechanisms of preterm birth and elucidating 
factors that regulate uterine quiescence, initiation of 
labour, and the multiple host, agent, and environmental 
factors that cause aberrations in these normal processes 
of pregnancy. Understanding the reasons for racial and 
ethnic disparities in preterm birth will advance the ﬁ eld 
of pregnancy health broadly, as well as accelerate solu-
tions for those populations most in need. A multi-
disciplinary approach is needed to identify women at risk 
and discover new strategies for prevention including 
potential biomarkers, such as genomic, microbial, 
immunologic, and hormonal factors.
Although infectious and inﬂ ammatory processes 
contribute to a high proportion of early spontaneous 
preterm births [35], antibiotic treatment of reproductive 
tract infections, especially bacterial vaginosis and other 
remote site infections, has generally failed to reduce 
preterm risk [36]. Many pre-existing chronic conditions 
and medical complications of pregnancy may result in 
increased risk of preterm delivery, such as pre-eclampsia, 
hypertension, aberrations in placentation and placental 
growth, diabetes and infectious diseases. Identifying 
mechanisms of these conditions, and strategies for early 
detection, prevention, and care, represent an important 
need for reducing the global burden of preterm birth. 
New strategies for prevention are particularly urgent for 
use in low- and middle-income settings where rates are 
highest.
Development research
Equipment and commodities are considered essential for 
neonatal care units in high-income countries, yet for 
many such units in low-income settings, basic equipment 
and essential medicines are not available or functional. 
Development of robust, ﬁ t-for-purpose equipment, is a 
critical next frontier for referral care for premature babies 
in the settings where most die, especially for care in 
hospitals [6]. Some examples include technologies for 
ventilatory support, novel surfactant formulations, safe 
and eﬀ ective intravenous ﬂ uid and drug administration, 
devices for testing bilirubin levels for jaundice and 
innovative phototherapy equipment [6]. New and 
eﬀ ective methods for monitoring and management of 
maternal complications and preterm labour could make a 
major contribution. Commodities, such as antenatal 
corticosteroids, could reach more women and babies 
though innovation for example in single-dose syringes or, 
ideally, needle-free devices [37].
Delivery research
Delivery or implementation research addresses how 
interventions can be best implemented, especially in 
resource-constrained settings where coverage inequali-
ties are more pronounced so that all families are reached 
with eﬀ ective care. Implementation research and pro-
gram evaluation evaluates how best to achieve wide scale 
coverage of interventions, including prevention particu-
larly family planning and such as care of women with 
infectious diseases such as malaria, HIV and STIs; 
improved nutrition; smoking cessation; and reducing 
maternal workload. In many high-income countries and 
those with emerging economies, there is evidence of an 
increase in late preterm deliveries due to elective induc-
tions and caesareans without clear medical indication 
[38]. More information is urgently needed from both 
providers and patients on the reasons for these shifts in 
clinical practice and how to promote more conservative 
obstetric management.
Th e vast majority of published studies on neonatal care 
relate to high-technology care in high-income settings 
[39]. Implementation research from low- and middle-
income settings is critical to inform and accelerate the 
scale up of high-impact care, such as KMC and neonatal 
resuscitation [19,21,40]. Evaluation of context-speciﬁ c 
neonatal care packages regarding outcome, cost and 
economic results is important, including adaptations such 
as task shifting to various cadres and use of innovative 
technologies [41]. Th ere is also a need to understand how 
to screen more eﬀ ectively for and treat possible 
prematurity-related cognitive, motor and behavioural 
disabilities, including in older children. In addition, the 
economics of preterm birth prevention and care, including 
the cost-beneﬁ t and cost-eﬀ ectiveness of interventions 
delivered singly or as a package across the continuum of 
care and in diﬀ erent settings and populations as well as the 
costs of doing nothing, need to be better studied [12,42].
Building the platform to accelerate research
Underlying this entire research agenda is the develop-
ment and implementation of the capacity to advance the 
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science of prevention of preterm birth, manage preterm 
labour and improve care of premature babies. Standard 
case deﬁ nitions of the types and causes of preterm birth 
are being developed [31,32] and will be critical to 
accelerating discovery and making comparisons across 
studies from basic science to clinical trials and program 
evaluation. Multi-country studies in middle- and low-
income countries tracking pregnant women with im-
proved and accurate gestational dating may help contri-
bute to improved pregnancy monitoring and a better 
understanding of all pregnancy outcomes for women, 
stillbirths and newborns. Improved communication and 
collaboration among researchers investigating these 
linked outcomes will provide an opportunity to accelerate 
the discovery, development and delivery of innovation, 
especially across disciplines and between laboratory 
benches and remote and under-resourced hospitals. 
Expanding training, research opportunities and mentor-
ship for researchers in low-income settings hold great 
promise in developing a pipeline of expertise to advance 
the science with the skills to use this science eﬀ ectively to 
promote change [30].
Potential for lives saved
To understand the impact of evidence-based interven-
tions on deaths due to complications of preterm birth, we 
considered analyses including historical data from high 
income countries (Figure 4), recent change in middle 
income countries (Figures 5 and 6) and a new analysis 
using lives saved modelling.
Figure 4. Historical phasing of reductions in neonatal mortality rates in the United Kingdom and United States during the 20th century. 
Source: Born Too Soon, Chapter 6 [75]. Data sources for UK and US historical data: (CDC, 2012, Offi  ce for National Statistics, 2012, NIH, 1985, Smith et 
al., 1983, Jamison et al., 2006, Lissauer and Fanaroff , 2006, Baker, 2000, Philip, 2005, Wegman, 2001) [54-62]. With thanks to Boston Consulting Group. 
Note: more information on history of neonatal mortality reduction in UK and USA available (Lawn et al, 2013) [6]. Data sources for Afghanistan, India, 
Brazil, and Russia from Child Health Epidemiology Reference Group/World Health Organization cause of death estimates for 2010 from Liu et al., 
2012 [50].
Lawn et al. Reproductive Health 2013, 10(Suppl 1):S6 
http://www.reproductive-health-journal.com/content/10/S1/S6
Page 8 of 20
Figure 5. Countries that have halved their deaths due to preterm birth in just one decade.
Several low- and middle-income countries have demonstrated a 50% reducƟon in preterm-specŝĮc 
neonatal deaths in low- or middle-resource ƐĞƫngs (Figure 6). Two of these countries — Sri Lanka and 
Turkey — are brieŇy described here. ŝīerences between approaches are immediately apparent, as 
countries customise their approach to availability of resources and health systems context.  
 
TURKEY 
Turkey, an upper middle-income country, has made signiĮcant progress in health care over the past 
decade.  Health system transformaƟon was comprehensive, but maternal and neonatal health policies in 
parƟcular played a central role.  As a result, the neonatal mortality rate dropped from 21 per 1,000 live 
births in 2000 to 10 per 1,000 live births in 2010 [63].  Births with a skilled ĂƩendant rose from 83% in 
2003 to more than 90% in 2009, and insƟtuƟonal facility births rose to more than 90% by 2009 [64].  In 
fact, Turkey achieved in a decade what took 30 years in the OECD countries.  
 
Part of Turkey’s success was through the implementaƟon of demand and supply strategies. There was 
sigŶŝĮcant promoƟon of antenatal care and facility births, including cash incenƟves and free 
accommodĂƟon in maternity waiƟng homes in ciƟes for expectant women from remote areas [65]. In 
ĂĚĚŝƟŽŶ, wider public health approaches were an important founĚĂƟŽn, such as focused eůŝŵŝŶĂƟon of 
maternal and neonatal tetanus, brĞĂƐƞeeding promoƟon and UNICEF "baby-friendly" hospitals 
campaigns. Turkey invested in health systems improvements, such as systemaƟzing referral to neonatal 
care with transport systems, and upgrading neonatal intensive care units, focusing on nursing staī skills 
and standardizaƟon of care, especially for neonatal resuscitaƟon [66]. 
 
SRI LANKA 
Sri Lanka, a lower middle-income country, has ďĞŶĞĮted from reĚƵĐƟon in NMR as a result of policies 
and gradual improvements in health care that have been conƟnually implemented over the past Įve 
decades.  Despite relaƟǀĞůǇ low per capita income, Sri Lanka has achieved impressive results and has 
oŌen been cited as an example of success for ƌĞĚƵĐƟon of maternal mortality through a primary health 
care approach [67]. 
 
Many of these advances have come due to Sri Lanka's investment in primary care iniƟaƟves, as well as 
provision of free health care at government facŝůŝƟes.  Antenatal care coverage is at 99% for the country, 
with approximately 51% of pregnant woman having more than 9 antenatal visits.  Skilled birth 
ĂƩendance at delivery is universal (99%).  Postnatal care is also robust, with 90% of women receiving 
public health midwife visits within 10 days of discharge [68, 69].   
 
From an NMR of 80 per 1,000 live births in 1945, Sri Lanka progressed steadily to 22 per 1,000 live births 
by 1980, and now to around 10 per 1,000 live births [63, 69]. More recent advances included 
reinvigoraƟon of community-based health care, including maternity clinics, and strengthening of referral 
and transportaƟŽŶ networks, such that women in preterm labour are rapidly transported to appropriate 
secondary and terƟĂry care centres. A recent focus has been addiƟonal investment in terƟary care 
centres equipped for neonatal intensive care, training of specialists and investment in more complex 
technologies (personal coŵŵƵŶŝĐĂƟŽŶ͕ Prof. D.G. Harendra de Silva). 
Figure 6. Well-preforming countries for preterm-specifi c neonatal mortality reduction by region. Source: Born Too Soon, Chapter 6 [75]. 
Analysis conducted using data from Liu et al., 2012 [50]. Credit: Boston Consulting Group with the Global Preterm Birth Mortality Reduction Analysis 
Group.
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History lessons from neonatal mortality reduction in high 
income countries
Th e historical data from the United States and United 
Kingdom (Figure 4) shows that a moderate increase in 
coverage of selected interventions results in a mortality 
reduction, even in the absence of neonatal intensive care. A 
number of lessons can be drawn from this historical data:
Basic care and infection case management interven-
tions have an eﬀ ect on neonatal deaths and on deaths 
amongst moderate and late preterm births, which 
account for over 80% of preterm births.
More targeted care is necessary for reducing deaths 
among babies 28 to <32 weeks and this reduction 
could be accelerated as higher-impact interventions 
are now known, such as antenatal corticosteroids, 
surfactant, KMC and other enhanced methods of 
infant warming and feeding which were not available 
in the mid-20th century in the United States and 
United Kingdom.
Intensive care may be necessary to reduce deaths 
among extremely premature babies (< 28 weeks), who 
account for 5% of all premature babies though a larger 
proportion of deaths.
Lives saved modelling for preterm mortality reduction
A Lives Saved Tool (LiST) analysis examining projected 
lives saved with interventions for preterm birth was 
conducted for 75 Countdown to 2015 priority countries 
(Th ese countries are: Afghanistan, Angola, Azerbaijan, 
Bangladesh, Benin, Bolivia, Botswana, Brazil, Burkina 
Faso, Burundi, Cambodia, Cameroon, Central African 
Republic, Chad, China, Comoros, Congo, Democratic 
Republic of the Congo, Côte d’Ivoire, Djibouti, Egypt, 
Equatorial Guinea, Eritrea, Ethiopia, Gabon, Th e 
Gambia, Ghana, Guatemala, Guinea, Guinea-Bissau, 
Haiti, India, Indonesia, Iraq, Kenya, Democratic Republic 
of Korea, Kyrgyz Republic, Lao People’s Democratic 
Republic, Lesotho, Liberia, Madagascar, Malawi, Mali, 
Mauritania, Mexico, Morocco, Mozambique, Myanmar, 
Nepal, Niger, Nigeria, Pakistan, Papua New Guinea, Peru, 
Philippines, Rwanda, Sao Tome and Principe, Senegal, 
Sierra Leone, Solomon Islands, Somalia, South Africa, 
South Sudan, Sudan, Swaziland, Tajikistan, United 
Republic of Tanzania, Togo, Turkmenistan, Uganda, 
Uzbekistan, Vietnam, Yemen, Zambia, and Zimbabwe.). 
LiST is a free and widely used module in a demographic 
software package called Spectrum, which allows the user 
to compare the eﬀ ects of diﬀ erent interventions on the 
numbers of maternal, neonatal and child deaths and 
stillbirths, as well as stunting and wasting [43]. Th e 
modelling methods have been widely published including 
discussions of the limitations, which are particularly 
related to the lack of coverage data for many of the 
speciﬁ c interventions [44-47].
Table 2 shows the interventions included in the LiST 
analysis that prevent preterm births and improve survival 
of premature babies. We considered the period from 
2010 to 2015 and then through 2025 to allow for a more 
feasible time frame to scale up care and progress on the 
prevention agenda. Th e results of the LiST analysis found 
that 84% of premature babies (more than 921,000 lives) 
could be saved in 2025 if these interventions were made 
universally available (95%). Full coverage of antenatal 
corticosteroids alone resulted in high mortality reduc-
tions, a 41% decrease from 2010 [20]. Implementing 
KMC alone also suggests that a high reduction of deaths 
could be achieved [21], averting approximately 531,000 
neonatal deaths in 2025. If these two interventions were 
added to existing health system packages, especially 
noting the recent shifts to more facility births in Africa 
and Asia, then a high impact is possible even in a rela-
tively short time frame.
Table 2: Estimated lives saved of premature babies in settings with universal coverage of interventions
 By 2015 By 2025
Intervention reaching  Also saves mothers % Deaths  % Deaths
95% coverage or other babies averted Lives saved averted Lives saved
Family planning* M, SB, N 24 228,000 32 345,000
Antenatal corticosteroids N 40 373,000 41 444,000
Antibiotics for pPRoM N 9 85,000 9 101,000
Immediate assessment and simple care of  N 5 44,000 5 53,000
all babies
Neonatal resuscitation N 7 65,000 7 77,000
Thermal care N 15 142,000 16 171,000
Kangaroo mother care N 48 452,000 48 531,000
Interventions implemented together M, SB, N 81 757,000 84 921,000
Note: interventions marked with M will also save maternal lives, SB would avert stillbirth, and N will save newborns dying from causes other than preterm birth.
* Family planning scaled to 60% coverage or to a level whereby the total fertility rate is 2.5.
Note that obstetric care would also have an impact, but is not estimated separately
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Targets for action by 2025
Th e Born Too Soon report initiated a process towards 
achieving goals for preterm birth prevention and 
presented a new goal for the reduction of deaths due to 
complications of preterm birth (Figure 7) [48]. Th e latter 
goal was set through consultation by a group of technical 
experts, and several analyses were undertaken to inform 
this target, notably (1) projections by country of the 
deaths due to preterm birth from now until 2025, 
assuming no change in trends and assuming expected 
changes in Gross National Income (GNI); (2) reduction 
in preterm-speciﬁ c neonatal mortality if the historical 
trends from the United Kingdom or the United States 
(Figure 4) were applied or if more rapid recent reductions 
in middle-income countries were applied (Figures 5 and 
6); (3) preterm-speciﬁ c neonatal mortality reductions 
predicted based on coverage changes according to the 
Lives Saved Tool Modelling (Table 2). Th ese analyses 
used data from UN demographic projections of births 
[49] and the Child Health Epidemiology Reference 
Group/World Health Organization neonatal cause of 
death time series, 2000 to 2010 [50].
Using the results from analyses of the three future 
scenarios (Figure 8), a target for mortality reduction of 
preterm births was set and agreed by the technical 
experts (Figure 7).
Scenario 1: “Business as usual”
Should governments and the global community take no 
further direct action to address deaths due to preterm 
birth, mortality will decline by 24% by 2025 according to 
an analysis of regional trends over the past decade and 
forward projection (or 16%, if the projection is based on 
forecasted GNI change) (Figure 4). Given this scenario 
and taking into account changing numbers of births, the 
global total of preterm deaths will not reduce signiﬁ cantly 
by 2025, with around 900,000 premature babies continu-
ing to die every year.
Scenario 2: Countries take action to catch up with top 
performers within their region
Preterm mortality could be halved by 2025 if govern-
ments took action now to match the top performers 
within their regions or to match the historical reductions 
in the United States and the United Kingdom from basic 
interventions before widespread use of intensive care 
(Figure 4). Th e examples of Sri Lanka and Turkey (see 
Figure 5) present examples of signiﬁ cant reduction in 
mortality, halving deaths in 10 years linked to scale up of 
intensive care. Even those countries with higher mortality 
rates that are not yet ready to scale up intensive care 
could see a 50% reduction as shown in the mid-20th 
century in the United States and the United Kingdom. 
Figure 7. Targets for action by 2025.
Targets for care of preterm babies 
The Born Too Soon report included a new goal for the reducƟon of deaths due to preterm birth [48]. 
The global goal is broken down into two diīerent country groups: those that have already achieved a 
low level of neonatal mortality (less than 5 per 1,000 live births) and those countries that have not yet 
achieved this level. Three scenarios informed the target seƫng for mortality reduĐƟon for premature 
babies (Figure 8). 
- For the countries that have already reached a neonatal mortality rate (NMR) of 5 per 1,000 live births 
or below by 2010: The goal is to eliminate remaining preventable preterm deaths, focusing on 
equitable care for all and quality of care to minimise long-term impairment. 
- For countries with a neonatal mortality rate above 5 per 1,000 live births in 2010: The goal is to 
reduce their preterm birth-aƩributable mortality by 50% between 2010 and 2025. This reĚƵĐƟon will 
mean that 550,000 premature babies will be saved each year by the target year of 2025. In addiƟon, 
more babies will be saved who are moderately preterm but die of other causes (e.g. infeĐƟons). 
 
Target for preterm birth prevenƟon 
The Born Too Soon report also called for a technical expert group to create a goal for reĚƵĐƟon of 
preterm birth rate by 2025 for announcement on World Prematurity Day 2012 [48]. The group published 
a paper in The Lancet detailing the Įndings of a comprehensive analysis of preterm prevalence data 
(2000–10) with analyses and projecƟons for 39 countries with reliable trend data [11]. The authors 
suggested the conservaƟve target of a reůĂƟve reĚƵĐƟon in preterm birth rates of 5% by 2015. This 
recommeŶĚĂƟon is based on analysis that if these highest-income countries were to fully implement 
Įve intervenƟons to prevent preterm births, including smoking ĐĞƐƐĂƟon and reducing the number of 
elecƟǀĞ caesareans, an average 5% reůĂƟǀĞ reduction in preterm birth could be achieved by 2015, 
varying from 8% ƌĞĚƵĐƟon in the USA to much smaller reĚƵĐƟŽŶƐ in most European countries, and only 
2% in the UK. TheseŝŶƚĞƌǀĞŶƟŽŶƐĂre limited impact and none are simple to implement. TheĮndings highlight  
the urgent need for preterm birth research especially in low-income seƫngs with the highest burden where 
the causes of prematurity might diīer and have simpler soluƟons such as birth spacing and treatment of 
infecƟons in pregnancy.  
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Th is reduction is achievable with improved essential care 
of premature babies and better case management of 
infections and respiratory distress syndrome, especially 
since the deaths of moderately-preterm babies are the 
most common and preventable ones.
Th ere are high-impact, cost-eﬀ ective interventions 
currently at low coverage [5,6], such as antenatal cortico-
steroids and KMC, that could signiﬁ cantly accelerate 
progress, which were not available in the United States 
and the United Kingdom in the middle of the 20th 
century when the neonatal mortality rate (NMR) was 
signiﬁ  cantly reduced. Hence, it would be expected, with 
the inclusion of these and other innovations, that 
mortality reduction could be more rapid than for the 
historical examples.
Scenario 3: Countries achieve universal coverage of basic 
interventions
Should governments adopt universal coverage of inter-
ventions (95%) ensuring that every woman and child who 
needs an intervention receives it, then, according to the 
LiST analysis (Table 2) and the historical data (Figure 4), 
countries could achieve an 84% reduction of 1.1 million 
deaths due to preterm birth complications. While 
ensuring a 95% coverage rate is ideal and would result in 
a major mortality reduction, this process will take time. 
Initiating these changes can start to move countries 
toward their goal of preterm mortality reduction while 
also preventing death due to other causes of newborn 
death, as well as maternal deaths and stillbirths, through 
shared interventions such as skilled care at birth.
Call to action
Born Too Soon is sobering in the news of a large burden 
and in the personal stories of loss behind that burden. Yet 
this is also a story of hope in the signiﬁ cant opportunities 
for change, especially as we approach the ﬁ nal sprint for 
the MDG 4 target and aim to maintain momentum beyond 
2015. Th ese ﬁ rst-ever country estimates of preterm birth 
leave us without the excuse of ignorance [3]. In 2010, 15 
million babies — more than 1 in 10 births — were born too 
soon, an emotional and economic toll on families, 
communities and countries. Th e problem is increasing - 
for the countries with 20-year trend data, the majority 
show an increase in preterm birth rates [3]. Additionally, 
the burden is not shared equally, with the impact of 
preterm birth falling most severely on the poorest families 
and in low- and middle-income countries where health 
systems are less prepared to respond. Th ere are also high 
preterm birth rates in many high-income countries, 
including the United States. Preterm birth is a problem 
that we all share; therefore, the solutions must also be 
shared, and won through cooperation, collaboration and 
co ordination of the many constituencies and stakeholders.
Figure 8. Results of three scenarios of preterm-specifi c mortality reduction to 2025. Source: Born Too Soon, Chapter 6 [75]. Analysis 
conducted by Mortality Reduction Goal Group and Boston Consulting Group using multiple data sources (Liu et al., 2012; EIU GDP projections 
2010 to 2030; World Population Prospects, 2010; UN Department of Economic and Social Aff airs; LiST analysis) [50, 52, 53]. Note: Analysis is for 
countries with NMR of more than 5 per 1,000 live births; other countries are excluded. Interventions in the LiST analysis included KMC, antenatal 
corticosteroids, antibiotics for pPRoM, skilled birth attendance, and others.
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Table 3. Everyone has a role to play: actions for the six key constituency groups involved in Every Women Every Child
Governments and policy-makers at local, national, regional and global levels:
Invest
•  Set national targets for improved survival of premature babies and increase funding to ensuring equitable access to quality care to meet these targets by 
2025.
Implement
• Strengthen health systems for quality maternal and neonatal care, including improved community awareness and demand for RMNCH services and adopt 
policies to promote universal access to quality preconception and maternal and perinatal services.
Innovate
• Promote the discovery, development and delivery of aff ordable and essential medicines, new technologies and novel models for training and services to 
prevent preterm birth and improve care of premature babies.
Inform
• Improve systems for collecting, evaluating and disseminating data on preterm birth rates, mortality, disability, quality of life and equitable coverage of 
evidence-based interventions to track progress towards MDGs 4 and 5 for maternal and child survival.
The United Nations and other multilateral organistions:
Invest
• Support countries develop and align their national health plans, including costing and tracking implementation to achieve the health MDGs and preterm 
birth mortality-reduction targets.
Implement
• Defi ne norms and guidelines to support eff orts to improve women’s and children’s health, and encourage their adoption through provision of technical 
assistance and programmatic support for the prevention and treatment of preterm births.
Innovate
• Generate and disseminate evidence on preterm birth and provide a platform for sharing best practices, and use the UN Commodities Commission to 
address gaps for essential equipment and medicines (e.g., antenatal corticosteroids).
Inform
• Support the production, dissemination and use of coverage data for evidence-based interventions through the Countdown to 2015 and Commission for 
Information and Accountability through the independent Expert Review Group.
Donors and philanthropic institutions:
Invest
• Provide sustained long-term support in line with national health policies and RMNCH plans that incorporate preterm births and are harmonised with other 
related global health initiatives.
Innovate
• Support high-priority research eff orts to address solution gaps and implementation research to inform the scale up of evidence-based interventions to 
reduce preterm deaths.
Inform
• Promote transparent tracking of commitments and accountability and of long-term improvements in national health management and information systems.
The business community:
Invest
• Invest additional resources to develop and adapt devices and commodities to prevent and treat preterm birth in low-income settings using innovative 
partnerships and business models.
Implement
• Scale up best practices and partner with the public sector to improve service delivery and infrastructure for prevention and management of preterm birth.
Innovate
• Develop aff ordable new diagnostics, medicines, technologies and other interventions, including social and behavioural change, for preterm birth and make 
them available to the most vulnerable and marginalised.
Inform
• Use and strengthen existing tracking systems for commodities and devices to improve supply chain logistics.
Academic and research institutions:
Invest
• Agree upon and promote an innovative research agenda for prevention of preterm birth and improved pregnancy outcomes and implementation research 
to reduce deaths from preterm birth.
Implement
• Build capacity at research institutions, especially in low- and middle-income countries, and train professionals.
Innovate
• Advance policy development by improving the metrics for impairment outcomes as well as preterm birth rates, and link to other pregnancy outcomes, 
reporting on trends and emerging issues relating to preterm births.
Continued overleaf
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A number of speciﬁ c actions, pursued by all partners 
and applied across the RMNCH continuum of care, will 
help prevent preterm birth and associated mortality, and 
have an immediate, profound and sustained impact on 
human capital. Th e seven constituencies, as identiﬁ ed by 
Every Woman Every Child [7], have four action themes, 
which link closely to the principles of Act, Monitor and 
Review recommended by the Commission on 
Information and Accountability for Women’s and 
Children’s Health.
Invest
Bring both ﬁ nancial and other resources to address 
maternal and newborn health and the burden of preterm 
birth.
Implement
• Adapt integrated packages of care, considering 
contexts, and tailored to local health service delivery 
channels.
• Increase reach of existing preventive interventions in 
the preconception period, especially family planning, 
and including adolescent-friendly services.
• Ensure that every woman receives the high-quality 
care she needs during pregnancy, birth and postnatally, 
especially if she is at risk of preterm birth. Th ere 
should be greater emphasis on the universal provision 
of ante natal corticosteroids, building on the work of 
the UN Commission on Life-Saving Commodities for 
Women and Children as an opportunity to accelerate 
progress.
• Undertake immediate action to scale up KMC as a 
standard of care for all preterm babies under 
2,000 grams, regardless of resource setting.
• Improve methods for diagnosing and treating 
prematurity-related impairment in childhood.
• Ensure that every family has the support they need, 
immediately after birth of a premature baby, following 
its loss, or living with a child with prematurity-
associated disability.
Table 3. Continued
Inform
• Strengthen global networks to disseminate new research fi ndings and best practice related to preterm birth through leveraging the momentum from Born 
Too Soon and commitments of these institutions.
Health care workers and their professional organisations:
Invest
• Advocate for and participate in evidence-based training, deployment and retention of workers with the necessary skills to address the burden of preterm 
birth.
Implement
• Use evidence-based standards to prevent or treat preterm births; implement training; and update curricula with evidence-based interventions. Treat women, 
newborns and children with respect and sensitivity.
Innovate
• Work in partnership to provide universal access to the essential package of interventions, including both prevention and care, and involving task shifting 
where appropriate.
Inform
• Improve data collection to track preterm births and measurements, such as consistent assessment of gestational age, birthweight, cause of death, data on 
impairment and retinopathy of prematurity.
Civil society:
Invest
• Advocate for increased attention to the health of women, newborns and children through strengthening parent groups and conducting national campaigns 
focusing on preterm birth.
Implement
• Strengthen community and local capabilities to scale up implementation of interventions for preterm birth and support families who have lost babies or 
require long-term support for disability.
Innovate
• Develop and test innovative approaches to deliver essential services for prevention and care, particularly ones aimed at the most vulnerable and 
marginalised people.
Inform
• Educate, engage and mobilise communities to improve health education and care, beginning in adolescence; promote cost-eff ective solutions; track 
progress and hold all stakeholders at global, regional, national and local levels accountable for their commitments; promote accountability through the 
issuance of annual Countdown to 2015 country data profi les and global and national reports that document preterm birth rates and associated mortality 
and coverage of evidence-based interventions.
Source: adapted from Born Too Soon report, chapter 6 [48]
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Inform
Improve the data for preterm birth rates, mortality, 
impair ment and their causes, with regular tracking of 
coverage, quality and equity gaps, as is done through 
Countdown to 2015 and linked to the work of the 
Commission for Information and Accountability using 
the data for action and accountability, including the 
establishment of national birth registrations.
Innovate
Conduct multi-country collaborative research on the:
• Etiology of preterm birth, advancing the understanding 
of strategies to prevent and treat maternal health 
conditions associated with preterm birth (e.g., pre-
eclampsia and gestational diabetes) and improving 
identiﬁ cation of diagnostic markers and related 
screening tools.
• Implementation research to develop and deliver 
innovations to reach the poorest.
Table 3 details actions for the seven constituencies and 
Figures 9-14 provide examples of action. Th is agenda is 
ambitious, yet it can and must be accomplished if the 
actions are to be given the visibility, funding and attention 
they deserve. To be successful in our goals, the consti-
tuencies identiﬁ ed must work together collaboratively 
and in partnership in ways that are transparent to all, 
vigorous and accountable.
All of the partners, donors and contributors involved in 
the Born Too Soon movement see the report and this 
supplement as important next steps towards a world 
Figure 9. Government – national integrated campaign for preterm births.
Parents, advocates and civil society have captured the ĂƩeŶƟon of governments and monitored 
progress in the United States through support of an annual Premature Birth Report Card. The Report 
Card, a familiar means of assessing progress for school-age children, has been a powerful tool used in 
the United States to prevent preterm birth and its serious health consequences. These grades, used as a 
rallying point, have helped bring visibility and promote change. Issued by the March of Dimes every year 
since 2008, the Report Cards assign a leƩer grade to the United States and to each of 50 state 
governments. In ĂĚĚŝƟon, they summarise the ĂĐƟŽŶƐ that must be taken to fund prevenƟon programs, 
address health care access and bring about needed change in health care systems. 
Transparency and obũĞĐƟǀŝƚǇ of the data and analysis are important factors in the success of the Report 
Cards. Each year, great care is taken to explain the methodology for grade determinĂƟŽŶ and the basis 
of comparison to other states. Use of the Report Card grades by state governments has grown since the 
Report Cards were ĮƌƐt launched in 2008, and coverage by local media is consistently strong. 
One southern U.S. state, with the second highest preterm birth rate in the country, has received an “F” 
on its Report Card every year since 2008.  The failing grade mobilised state health oĸcials in early 2012 
to launch a statewide ŝŶŝƟaƟve with the goal of reducing rates.  In this state and many others, media 
events featuring prominent public ŽĸĐŝals are held to announce Report Card grades or report on state 
progress to address preterm birth. The U.S. Surgeon General has also parƟcipated in media outreach to 
publicise the Report Cards and their recommended 
ĂĐƟŽŶƐ͘  
 
Sustained Ğīort by healthcare leaders and advocates at 
all levels, inside and outside of government, has 
elevated the issue of preterm birth on the naƟon’s 
health agenda, contribƵƟng to an announcement of 
new federal resources to test promising ƉƌĂĐƟĐĞƐ in 
February 2012. Soon aŌer, the AssociaƟon of State and 
Territorial Health Oĸcials (ASTHO) joined with the 
March of Dimes to ask state health Žĸcials to pledge to 
reduce preterm birth rates in their states, and the 
pledge was incorporated into Report Cards.  Top health 
oĸcials in every state, along with Puerto Rico and the 
District of Columbia, signed the pledge.   
 
As federal and state governments devote ĂƩeŶƟon and 
resources to the problem, the Report Cards will 
conƟnue to mobilise stakeholders and mark progress. 
 
More informaƟon is available at ŚƩƉ://www.marchofdimes.com/mission/prematurity-reportcard.aspx 
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where every woman, every newborn and every child is 
given the best chance to survive and thrive.
Conclusion - Together rapid change is possible
Over the last decade, the world has changed. Just as it is 
no longer acceptable for people with HIV/AIDS to 
remain untreated because they live in poor countries, it is 
no longer acceptable for women to die while giving birth. 
Likewise it should be unacceptable for almost 3 million 
newborns, to die, including those who are born too soon. 
Over three-quarters of premature babies who die could 
be saved if basic care reached them and their mothers. 
Rapid progress is possible. At the same time, research 
and innovation for preterm birth prevention is urgent. 
Th ese actions would reduce disability and chronic 
disease, improve reproductive and maternal health, and 
build sustainable health systems. We need more frontline 
health workers who are skilled and conﬁ dent in newborn 
care. We need facilities equipped with life-saving 
commodities, and girls, and women who are educated, 
and enabled, can protect their own health, and that of 
their babies.
Additional File
Figure 10. The United Nations - Life-saving Commodities for Women and Children— potential for action to reduce preterm deaths.
The United NaƟons (UN) Secretary General’s The Global Strategy for Women’s and Children’s Health 
highlighted inequiƟĞƐ for women and children around the world and advocated for universal access to 
basic health care for all esƐĞŶƟĂů medicines and other commodiƟes necessary to achieve MDGs 4, 5 and 
6. Too ŽŌĞŶ, cost-eīecƟve, high-impact health commodiƟes do not reach the women and children who 
need them. Some of the barriers to access include the lack of Ăīordable products, lack of age-
appropriate formulaƟons, weak supply chains, lack of awareness of how, why and when to use these 
commoĚŝƟes and inadequate regulatory capacity at the country level to protect the public from sub-
standard or counterfeit medicines that cause harm. 
 
The UN has established a Commission to address this issue, bringing together industry, civil society and 
technical experts to champion the eīort to reduce the barriers that obstruct access to essenƟal health 
commoĚŝƟĞƐ͘  Selected commoĚŝƟĞƐ will be: 
1. High-impact and eīeĐƟve, addressing major causes of death and disease among children under ĮǀĞ
years of age and women during pregnancy and childbirth 
2. Inadequately funded by exisƟng mechanisms 
3. Ready for innovaƟon and rapid scale up in product development and market shaping: 
 
A list of 13 commoĚŝƟes has been selected, and includes four with potenƟal to reduce the 3 million 
deaths amongst newborns, especially those who are preterm. All of these commodiƟes are high-impact, 
low-coverage, and none has had previous global funding: 
ͻ Antenatal ĐŽƌƟĐŽsteroids reduce the risk of severe respiratory complicaƟons by half if given by 
injeĐƟon to women in preterm labour, but this commodity is low-coverage even in middle-income 
countries, due to a number of supply and regulaƟon issues and low awareness among health care 
providers. It has been esƟmated that up to 400,000 babies could be saved with this intervenƟon, and 
the unit costs, if dexamethasone is used, is around one dollar per dose. 
ͻ Chlorhexidine cord care has recently been shown to be ĞīecƟve in reducing neonatal deaths due to 
sepsis: 320,000 neonates die each year of sepsis and many of them are moderately preterm. Rapid 
policy and program uptake of chlorhexidine could save many of these babies. 
ͻ ResuscitaƟon devices and training mannequins have undergone recent innovaƟons, but are ƐƟůů not 
widely available in many high-burden countries with scope to reduce neonatal deaths from intrapartum 
insults, as well as from preterm birth complicaƟons. 
ͻ InjeĐƟon anƟbioƟcs, including gentamicin, are crucial for ƚƌĞĂƟŶŐ neonatal infeĐƟons and yet, due to 
low dosing, are ŽŌen mis-administered; innoǀĂƟŽŶƐ such as pre-packaged doses and needle-free 
technology could have a major eīect on reaching the poorest. 
 
PromŽƟon of a robust supply of quality products with fair pricing is a unique opportunity to accelerate progress 
and save lives of women and children, and could contribute to halving the 1.1 million deaths due to preterm birth. 
More informaƟon available at ŚƩp://www.everywomaneverychild.org/resources/un-commission-on-life-saving-
commodiƟes 
Additional fi le 1. In line with the journal’s open peer review policy, 
copies of the reviewer reports are included as additional fi le 1.
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Figure 11. Donors and philanthropic institutions - Helping Babies Breathe as an example of a public-private alliance to save newborns.
In 2010, the United States Agency for InteƌŶĂƟonal Development (USAID) ŝŶƐƟƚƵƚed a formal ƉƵblic-
private partnership, called Global Development Alliance, to accelerate the scale Ƶp of a ƐŝŵƉůŝĮĞd 
neonatal ƌĞƐƵƐĐitaƟon package, called Helping Babies Breathe (HBB). HBB broƵght together Ěŝīering 
skills with a professional association, American Academy of Pediatrics (AAP), civil society and ŝŶĚƵstry. 
Key constraints that had impeded scale Ƶp of neonatal resƵscitaƟon were in the lack of rŽďƵst, Įt-for-
pƵrpose eƋƵipment and the complexity of gƵidelines and training. AAP and others developed an 
evidence-based simpliĮed pictorial algorithm for basic neonatal reƐƵƐĐŝƚĂƟon. Laerdal designed and 
ŵĂŶƵĨacƚƵƌĞĚ low-cost eqƵŝpment, inclƵding bag and mask, a pengƵin ƐƵĐƟon device and Neonatalie (a 
robƵst training manneƋƵŝn). A non-ĞǆĐůƵƐŝǀĞ partnership with Laerdal facilitated the availability of these 
devices, as well as those of other mĂŶƵĨĂcƚƵrers. Save the Children’s role facilitated ƵƉtake, inƚĞŐƌĂƟon 
and sƵstainable scale ƵƉ with ministries of health in lower-income ĐŽƵŶƚƌies. The U.S. NaƟonal InƐƟtƵtes 
of Health (NIH) helped with evalƵaƟon. Other partners, ŝŶĐůƵĚŝŶŐ Johnson & Johnson and the LaƩer-day 
Saints CharŝƟes, have joined and generated momeŶƚƵŵ at global and coƵntry level. 
 
HBB was developed in response to evidence that neonatal reƐƵƐĐŝƚĂƟŽŶ training in ĨĂĐŝůŝƟes redƵces 
term intrapartƵm-related deaths by 30% ďƵt the coverage is low in reƐŽƵƌce-limited areas [19, 70].  In 
less than two years, 34 coƵntries have introdƵced HBB, 10 of which have developed naƟonal rŽůůͲŽƵƚ
plans. Evidence from several developing cŽƵntries sƵggests that basic neonatal resƵscitaƟon is an 
eīeĐƟǀĞ approach at scale to ƌĞĚƵĐĞ newborn mortality [71, 72]. 
 
More informaƟon available at hƩp://www.helpingbabiesbreathe.org/GDAinformĂƟon 
Figure 12. The business community - Industry partnership for innovative technology for preterm baby care in Asia.
Many countries lack the technical capacity and human and Įnancial resources to successfully implement 
facility- based neonatal intensive care.  Equipment failures, management and personnel training, and 
stock outs of consumables hamper health delivery Ğīorts. GE Healthcare and the East Meets West 
FoundĂƟon (EMW) have forged an alliance to solve these challenges. Building on the success of a 
program called Breath of Life, EMW and GE Healthcare are creĂƟng a suite of neonatal technologies that 
are durable, require few consumables, are easy to use and are ƐƉĞĐŝĮcally designed for sustainability in 
low-resource seƫngs.  The equipment is delivered in the context of a ŵƵůƟ-year program of training, 
monitoring, clinical supervision and technical support.  Since its launch by EMW in 2005, the Breath of 
Life program has been implemented in more than 280 hospitals across eight countries of South Asia, 
currently treaƟŶg more than 55,000 babies a year. 
 
Designed locally in Vietnam, EMW’s neonatal equipment has maintained a failure rate below 5% 
compared to more than 80% for donated equipment from Western countries.  Beyond core technologies 
of bubble CPAP, LED phototherapy and radiant warmers, the program also provides infeĐƟon-control 
systems, ambu-bags, baby bonnets and a long list of ancillary equipment.  Monitoring and training — a 
pervasive shortcoming of many technology-based programs — are core strengths of the Breath of Life 
program.  EMW staī typically monitor every hospital in the network 3 to 5 Ɵmes per week, and visit as 
ŽŌen as twice a month for extended technical and clinical training and supervision. 
 
In partnership with GE Healthcare, the Breath of Life program will be signiĮcantly expanded in scope and 
scale.  Future devices will be engineered according to local design principles and follow stringent quality 
and regulatory review processes.  As a global leader in the design and manufacture of advanced 
neonatal intensive care equipment, GE Healthcare can deliver and service these neonatal devices 
virtually anywhere in the world. Volume manufacturing should result in both lower costs and higher 
quality.  This alliance of EMW and GE Healthcare is a powerful example of what partnerships can 
accomplish to help reduce the rate of preterm birth.  
 
More informaƟon hƩp://www.eastmeetswest.org and ŚƩp://www.gehealthcare.com 
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Figure 13. Health care workers - Health care providers as champions of change for mothers and newborns.
A premature baby’s survival is dependent on both his mother’s survival and on care received from 
several health care professional groups: 
ͻ Obstetricians, who provide eīecƟve care to the woman, prevent or manage preterm labour 
ͻ Midwives, who ensure safe delivery and resuscitate if necessary 
ͻ Paediatricians, who undertake advanced resuscitaƟon and ongoing care if needed. Where most 
premature babies are born and die, there are few paediatricians and almost no neonatologists. 
 
This cross-unit team can save lives; however, if none of these groups takes responsibility for premature 
babies, where minutes count between life and death, then more babies will die. Indeed, nurses and 
midwives are the front line workers for millions of premature babies in faciliƟes in low- and middle-
income countries. However, there is an acute shortage internĂƟŽŶĂlly of neonatal nurses, or nurses who 
receive speciĮc training in newborn care, parƟĐƵůĂƌly in low-income countries [73]. Those nurses, who 
commit to newborn care, ŽŌen receive liƩle or no recogŶŝƟon for providing excellent care against all the 
odds. 
 
Regina Obeng has worked in the neonatal unit at the Komfo Anokye Teaching Hospital in Kumasi, Ghana 
for over 20 years [74]. Not acceƉƟng newborn deaths as inevitable, she has dedicated her life to saving 
babies in her crowded ward, where 350 to 400 newborns are cared for each month. She has been a 
consistent voice for these babies and their mothers, speaking up for more space, beƩer supplies and, 
especially, more ƐƚĂī and ways to retain skilled staī, and places for mothers to stay. Regina was 
awarded the InteƌŶĂƟŽnal Neonatal Nursing Excellence Award in 2010, given by the InternĂƟonal 
Conference of Neonatal Nurses (ICNN) together with Save the Children, the Council of InternaƟonal 
Neonatal Nurses (COINN) and the Neonatal Nurses AsƐŽĐŝĂƟŽn of South Africa (NNASA). Now her voice 
is even stronger in Ghana, raising public awareness about the issues facing mothers and newborn 
babies, parƟcularly prematurity, and has ŝŶŇuenced even the highest levels of the Ministry of Health to 
ensure neonatal nurses’ training will start in Ghana. 
Figure 14. Civil society - Chinese parents mobilising for their preterm babies.
Groups of parents aīected by preterm birth are an inŇƵĞŶƟal civil society group, supporƟng ĂīĞĐted 
families and being their voice in government and among health policy planners. The Home for 
Premature Babies (HPB) is an example of a parent group advocaƟng for improvements in care and 
support. As the largest preterm birth associĂƟon of parents and families among Chinese-speaking 
nĂƟons, the membership of HPB now exceeds 400,000 families. 
 
Formed in 2005 by Mrs. Jianian Ma, a mother of a very preterm baby, HPB now encompasses several 
foundaƟons that provide naƟŽnwide services in support of prevenƟon and care. With the sponsorship of 
the China NĂƟŽŶĂů ŽŵŵŝƩee for the Well-being of the Youth, HPB was established as a semi-
governmental organiǌĂƟon. This close central government Ɵe has helped ensure conƟnuity of HPB’s 
funding and the ability to partner more eīecƟvely with other organizaƟons in China. 
  
HPB has established three centres dedicated to the care of children with prematurity-related disabiliƟes; 
launched an inteƌĂĐƟve website to allow parents and prospĞĐƟve parents to ask quaůŝĮed medical 
experts about ways to help minimise the risk of having a preterm birth and how to care for their 
preterm baby; implemented a telephone hotline to provide immediate responses to parents’ quesƟons; 
and established a “Green Track” in more than 100 hospitals ŶĂƟŽŶǁŝĚe that allows families with a sick 
preterm child to see a paediatrician quickly. 
  
“As we have experienced in China, groups of parents ĂīĞĐƚĞĚ by preterm birth can be an independent 
and uniquely powerful grassroots voice, calling on government, professional organizaƟons, civil society, 
the business community and other partners in their countries to work together to prevent prematurity, 
improve care of the preterm baby and help support Ăīected families.” Dr. Nanbert Zhong, Chair, 
Advisory CommŝƩee for Science and InterŶĂƟonal Aīairs, HPB. 
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